Stock indices

Valuation of stock indices

Intrinsic value stock screeners

Chepakovich model stock screener

CriteriaMinMax
Upside/downside potential, %  
Market cap, US$ mln
Revenue, US$ mln
Revenue growth rate, %
Price-to-earnings (P/E) ratio
Dividend yield, %
Price to book
Price to sales
Sales to assets
Debt-to-equity ratio
Return on assets (ROA), %      
Return on equity (ROE), %
Net profit margin, %

Graham-Dodd stock screener

Graham formula stock screener

Latest articles

Lockheed Martin - consistent profitability in the US defense sector

2021-06-02  Author: Stock Analyst  Category: Stock analysis

Our estimate of the fair value for Lockheed Martin at the end of 2021 is $125 billion, or $450.30 per share, which implies 17.1% upside potential from the current price level. The recommendation is "Buy".

Applied Materials excellent second quarter

2021-05-21  Author: Stock Analyst  Category: Stock news

We have a Buy recommendation for Applied Materials with a mid-term target price of $156.70, which implies 20.3% upside from the current level.

Exxon Mobil - long-term hold

2021-05-19  Author: Stock Analyst  Category: Stock analysis

To valuate the company, we used the multiples valuation method relative to peers, which gave a target capitalization of $286.3 billion, or $67.6 per share. This corresponds to an upside of 8.7% on a 12-month horizon. and a Hold rating. Including dividends, the upside is 14.3%.

Ameren shares have shown solid growth over the past three months

2021-05-14  Author: Stock Analyst  Category: Stock analysis

On May 11, Ameren, a Missouri-based electricity holding company, released its financial results for the first quarter of this year. The company's refined EPS for Q1 was $0.91 (+ 54.2% YoY), well ahead of the $0.75 consensus.

Exxon Mobil - hold and buy on pullbacks

2021-05-11  Author: Stock Analyst  Category: Stock news

Since our recommendation on March 24, Exxon Mobil has gained 11.9% to reach our target price of $63.80.

Cummins' quarterly figures beat Wall Street forecasts

2021-05-11  Author: Stock Analyst  Category: Stock news

The company's revenues for the reporting period grew by 22% YoY to $6.1 billion, which was better than market expectations of $5.3 billion, while sales in North America grew by 7% YoY.

Abbvie posted strong sales growth in Q1

2021-05-11  Author: Stock Analyst  Category: Stock analysis

Abbvie released its financial results for the 1st quarter of 2021 on Friday, April 30. What is in the numbers?

Alibaba shares retain upside potential

2021-05-06  Author: Stock Analyst  Category: Stock analysis

Since our recommendation of February 25, 2021, Alibaba shares are down 10.3%. The main reason for the decline was the main risk identified in our figure - regulatory pressure.

Con Edison remains one of the green transition leaders

2021-05-05  Author: Stock Analyst  Category: Stock news

Our current recommendation for ED shares is "Hold" with a target of $84.90, which corresponds to a potential of 8.7% excluding dividends. The expected dividend yield in 2021 is around 4%.

Exxon Mobil reports moderately positive 1Q financials

2021-04-30  Author: Stock Analyst  Category: Stock news

Exxon Mobil posted a moderately positive 1Q2021 report. Adjusted earnings per share rose 22.6% YoY to $0.65. Revenue rose 5.3% YoY to $59.2bn. Both parameters were 7-9% above consensus.

We expect strong Q1 performance from Cummins

2021-04-30  Author: Stock Analyst  Category: Stock news

We expect that the company's revenue in the reporting period will increase by 5.84% YoY to reach $5.3 billion, and the adjusted earnings per share may be about $3.46, which is 8.8% higher than in the same period. period of the last year.

Skyrizi and Rinvoq Can Help AbbVie Beat Consensus

2021-04-29  Author: Stock Analyst  Category: Stock analysis

One of the leaders in the US pharmaceutical industry, AbbVie, will release its 1Q08 financials on Friday, April 30. What to expect?